Relx (NYSE:RELX) Downgraded to “Sell” at Zacks Investment Research

Zacks Investment Research lowered shares of Relx (NYSE:RELX) from a hold rating to a sell rating in a report published on Wednesday, Zacks.com reports.

According to Zacks, “Relx PLC is engaged in providing information solutions. Its products and services comprise intellectual property content delivered through various media, including online, journals and books. The Company’s operating segments consists of Scientific, Technical & Medical, Risk & Business Information; Legal and Exhibitions. RELX PLC, formerly known as Reed Elsevier PLC, is based in LONDON, United Kingdom. “

RELX has been the topic of a number of other reports. UBS Group reiterated a neutral rating on shares of Relx in a research report on Thursday, October 7th. Societe Generale reiterated a buy rating on shares of Relx in a research report on Monday, August 2nd. JPMorgan Chase & Co. reiterated an overweight rating on shares of Relx in a research report on Friday, July 30th. BNP Paribas upgraded Relx from a neutral rating to an outperform rating in a research report on Thursday, July 1st. Finally, Barclays reiterated an overweight rating on shares of Relx in a research report on Friday, October 8th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of Buy and an average price target of $33.00.

NYSE RELX opened at $29.67 on Wednesday. The firm has a market cap of $57.38 billion, a PE ratio of 29.09, a price-to-earnings-growth ratio of 2.59 and a beta of 0.73. Relx has a one year low of $19.52 and a one year high of $30.77. The stock’s 50 day simple moving average is $29.97 and its 200 day simple moving average is $28.02. The company has a debt-to-equity ratio of 2.50, a current ratio of 0.53 and a quick ratio of 0.46.

The business also recently declared a dividend, which was paid on Monday, September 13th. Stockholders of record on Friday, August 6th were given a $0.3351 dividend. This is a positive change from Relx’s previous dividend of $0.17. This represents a dividend yield of 2.28%. The ex-dividend date was Thursday, August 5th. Relx’s dividend payout ratio (DPR) is currently 38.24%.

Large investors have recently bought and sold shares of the company. Stifel Financial Corp boosted its position in shares of Relx by 16.2% in the 1st quarter. Stifel Financial Corp now owns 192,309 shares of the technology company’s stock worth $4,839,000 after purchasing an additional 26,758 shares during the last quarter. Prudential Financial Inc. acquired a new stake in Relx during the 1st quarter worth $231,000. Ethic Inc. raised its stake in Relx by 80.8% during the 1st quarter. Ethic Inc. now owns 27,782 shares of the technology company’s stock worth $699,000 after buying an additional 12,417 shares during the period. Neuberger Berman Group LLC raised its stake in Relx by 6.9% during the 1st quarter. Neuberger Berman Group LLC now owns 605,559 shares of the technology company’s stock worth $15,076,000 after buying an additional 39,235 shares during the period. Finally, SG Americas Securities LLC raised its stake in Relx by 15.7% during the 2nd quarter. SG Americas Securities LLC now owns 99,765 shares of the technology company’s stock worth $2,661,000 after buying an additional 13,541 shares during the period. Institutional investors and hedge funds own 5.97% of the company’s stock.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.

See Also: Trading Strategy Methods and Types

Get a free copy of the Zacks research report on Relx (RELX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Relx (NYSE:RELX)

Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.